Ashwani Bahl

Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib

R. Charles Coombes, Sacha J. Howell, Simon Lord et al. · Nature Communications · 2023 · 54 citations · Full text

Potent Dual Inhibitors of TORC1 and TORC2 Complexes (KU-0063794 and KU-0068650) Demonstrate In Vitro and Ex Vivo Anti-Keloid Scar Activity

Farhatullah Syed, Hitesh J. Sanganee, Ashwani Bahl et al. · Journal of Investigative Dermatology · 2013 · 38 citations · Full text

Molecular Biology, Molecular Pharmacology, Signaling Pathway +17

THE β3-ADRENOCEPTOR AGONIST CL316243 PREVENTS INDOMETHACIN-INDUCED JEJUNAL ULCERATION IN THE RAT BY REVERSING EARLY VILLOUS SHORTENING

Andrew Anthony, Ashwani Bahl, I Oakley et al. · The Journal of Pathology · 1996 · 21 citations

Inflammation, Molecular Pharmacology, Anti-inflammatory +11

Mechanism of Action of Inhibition of Allergic Immune Responses by a Novel Antedrug TLR7 Agonist

Hiroyuki Matsui, Hideyuki Tomizawa, Kazuo Eiho et al. · The Journal of Immunology · 2012 · 18 citations

Asthma, Inflammatory Lung Disease, Lung Inflammation +22